ABNORMAL HAEMATOLOGICAL PARAMETERS IN EC 177 7 SUPPLEMENTARY Total study cohort: 894 patients Excluded based on adjuvant treatment: No adjuvant treatment: 550 patients Chemo or chemoradiation: 100 patients Other: 5 patients Solely receiving RT: 239 patients Excluded based on the ESGO/ESTRO/ESP risk groups: Low: 7 patients High-intermediate: 89 patients High: 49 patients Advanced/metastatic: 3 patients Patients within the intermediate risk group solely receiving VBT: 74 patients Excluded based on adjuvant treatment within the intermediate risk group: EBRT: 9 patients EBRT + VBT: 8 patients Figure S1. Flowchart secondary analysis
RkJQdWJsaXNoZXIy MTk4NDMw